Developing bispecific antibodies to prevent and treat Ebola.
NIAID-VRC-Research, Development, and Production to Support Ebola Bispecific Antibody Development
['FUNDING_OTHER'] · LEIDOS BIOMEDICAL RESEARCH, INC. · NIH-10722435
This study is working on new treatments and vaccines for Ebola by developing special antibodies that can help protect and treat people affected by the virus, so they can have better options if an outbreak happens.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LEIDOS BIOMEDICAL RESEARCH, INC. (nih funded) |
| Locations | 1 site (FREDERICK, UNITED STATES) |
| Trial ID | NIH-10722435 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and producing bispecific antibodies that can target the Ebola virus, aiming to provide both prevention and therapeutic options for those affected by the disease. The approach involves rapid response to infectious disease outbreaks, with a strong emphasis on developing clinical products that can be manufactured efficiently. Patients may benefit from these advancements through improved treatment options and potential vaccines that could protect against Ebola.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk of Ebola exposure or those who have been diagnosed with Ebola virus infection.
Not a fit: Patients who are not at risk of Ebola or those with other unrelated infectious diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments and vaccines for Ebola, significantly improving patient outcomes.
How similar studies have performed: Previous research has shown promise in developing bispecific antibodies for other infectious diseases, indicating potential success for this novel approach in Ebola treatment.
Where this research is happening
FREDERICK, UNITED STATES
- LEIDOS BIOMEDICAL RESEARCH, INC. — FREDERICK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CASE, CHRIS — LEIDOS BIOMEDICAL RESEARCH, INC.
- Study coordinator: CASE, CHRIS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Infectious Disease Pathway, Infectious Diseases, Infectious Disorder, Disease Outbreaks